Compound Detail
CHEMBL4103349
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4103349 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | JAHPQYLVEHINFS-LLVKDONJSA-N |
1
Targets
1
Activities
1
Assay Types
2
PK Parameters
7
Publications
0
Known Names
Molecular Properties
440.9
MW (Da)
4.39
ALogP
4
HBA
3
HBD
95.5
PSA (Ų)
0.48
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 9.3
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| C-X-C chemokine receptor type 2 CHEMBL2434 | IC50 | 9.3 | 9.3 | 0.5 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| Fu | 0.021 | - | Rattus norvegicus |
| Fu | 0.007 | - | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| C-X-C chemokine receptor type 2 | IC50 | = | 0.5012 | nM | 9.3 | Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombi... | 29406702 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 29406702 | 10.1021/acs.jmedchem.7b01854 | C-X-C chemokine receptor type 2 | 2 |
| 29406702 | 10.1021/acs.jmedchem.7b01854 | Blood | 2 |
| 29406702 | 10.1021/acs.jmedchem.7b01854 | Brain | 2 |
| 29406702 | 10.1021/acs.jmedchem.7b01854 | Unchecked | 2 |
| 29406702 | 10.1021/acs.jmedchem.7b01854 | MDCK-MDR1 | 1 |
| 29406702 | 10.1021/acs.jmedchem.7b01854 | No relevant target | 1 |
| 29406702 | 10.1021/acs.jmedchem.7b01854 | ADMET | 1 |
Data from ChEMBL 36 via Core Engine